Tusamitamab Ravtansine
82934

TargetCEACAM5
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameTusamitamab Ravtansine
- Delivery Days Customer23
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- Gene ID1048
- Target nameCEACAM5
- Target descriptionCEA cell adhesion molecule 5
- Target synonymscarcinoembryonic antigen related cell adhesion molecule 5; carcinoembryonic antigen-related cell adhesion molecule 5; CD66e; CEA; meconium antigen 100
- Protein IDP06731
- Protein NameCarcinoembryonic antigen-related cell adhesion molecule 5
- Scientific DescriptionTusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 , via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.81,2,3.
- Storage Instruction-80°C
- UNSPSC12352203